HuGE Literature Finder
Records 1-30
|
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens.
American journal of clinical oncology 2020 Dec . Marks Eric I, Matera Robert, Olszewski Adam J, Yakirevich Evgeny, El-Deiry Wafik S, Safran Howard, Carneiro Benedito |
|
Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing.
Oncology 2020 Jun 1-6. Zhou Jing, Zhao Zhengyi, Zhang Yuzi, Bao Celimuge, Cui Longgang, Cai Shangli, Bai Yuezong, Shen Lin, Zhang Xiaoti |
|
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Pancreatic Cancer Patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Dec . Goldstein Jennifer B, Zhao Li, Wang Xuemei, Ghelman Yael, Overman Michael J, Javle Milind, Shroff Rachna T, Varadhachary Gauri R, Wolf Robert A, McAllister Florencia, Futreal P Andrew, Fogelman David |
|
Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
BMC cancer 2018 Sep 18 (1): 926. Hoyer Juliane, Vasileiou Georgia, Uebe Steffen, Wunderle Marius, Kraus Cornelia, Fasching Peter A, Thiel Christian T, Hartmann Arndt, Beckmann Matthias W, Lux Michael P, Reis And |
|
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
Genetics in medicine : official journal of the American College of Medical Genetics 2018 Jul . Yurgelun Matthew B, Chittenden Anu B, Morales-Oyarvide Vicente, Rubinson Douglas A, Dunne Richard F, Kozak Margaret M, Qian Zhi Rong, Welch Marisa W, Brais Lauren K, Da Silva Annacarolina, Bui Justin L, Yuan Chen, Li Tingting, Li Wanwan, Masuda Atsuhiro, Gu Mancang, Bullock Andrea J, Chang Daniel T, Clancy Thomas E, Linehan David C, Findeis-Hosey Jennifer J, Doyle Leona A, Thorner Aaron R, Ducar Matthew D, Wollison Bruce M, Khalaf Natalia, Perez Kimberly, Syngal Sapna, Aguirre Andrew J, Hahn William C, Meyerson Matthew L, Fuchs Charles S, Ogino Shuji, Hornick Jason L, Hezel Aram F, Koong Albert C, Nowak Jonathan A, Wolpin Brian |
|
Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population.
Oncotarget 2018 Jun 9 (42): 26616-26624. Wang Shijia, Zhang Yue, Chen Min, Wang Yong, Feng Yifei, Xu Ziwei, Zhang Dongsheng, Sun Yueming, Fu Z |
|
Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of Breast Cancer Based on TCGA Database.
Journal of cellular biochemistry 2017 May . Liu Chang, Chang Hong, Li Xiao-Han, Qi Ya-Fei, Wang Jin-Ou, Zhang Ying, Yang Xiang-Ho |
|
Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma.
Anticancer research 2017 04 37 (4): 1729-1735. Okamoto Tatsuro, Kohno Mikihiro, Ito Kensaku, Takada Kazuki, Katsura Masakazu, Morodomi Yosuke, Toyokawa Gouji, Shoji Fumihiro, Maehara Yoshihi |
|
Current perspectives on CHEK2 mutations in breast cancer.
Breast cancer (Dove Medical Press) 2017 9 331-335. Apostolou Panagiotis, Papasotiriou Ioann |
|
Association of CHEK2 polymorphisms with the efficacy of platinum-based chemotherapy for advanced non-small-cell lung cancer in Chinese never-smoking women.
Journal of thoracic disease 2016 Sep 8 (9): 2519-2529. Xu Wen, Liu Di, Yang Yang, Ding Xi, Sun Yifeng, Zhang Baohong, Xu Jinfu, Su |
|
A Comparison between CHEK2*1100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis.
Oncology 2016 Mar 90 (4): . Huszno Joanna, Budryk Magdalena, Ko?osza Zofia, T?cza Karolina, Pamu?a Pi?at Jolanta, Nowara El?bieta, Grzybowska E |
|
Novel Nonsense Variants c.58C>T (p.Q20X) and c.256G>T (p.E85X) in the CHEK2 Gene Identified dentified in Breast Cancer Patients from Balochistan.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (3): 1089-92. Baloch Abdul Hameed, Khosa Ahmad Nawaz, Bangulzai Nasrullah, Shuja Jamila, Naseeb Hafiz Khush, Jan Mohammad, Marghazani Illahi Bakhsh, Kakar Masood-Ul-Haq, Baloch Dost Mohammad, Cheema Abdul Majeed, Ahmad Jam |
|
Novel Nonsense Variants c.58C>T (p.Q20X) and c.256G>T (p.E85X) in the CHEK2 Gene Identified in Breast Cancer Patients from Balochistan.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (7): 3623-6. Baloch Abdul Hameed, Khosa Ahmad Nawaz, Bangulzai Nasrullah, Shuja Jamila, Naseeb Hafiz Khush, Jan Mohammad, Marghazani Illahi Bakhsh, Kakar MasoodulHaq, Baloch Dost Mohammad, Cheema Abdul Majeed, Ahmad Jam |
|
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.
Oncogene 2015 Jan . Wang N, Ding H, Liu C, Li X, Wei L, Yu J, Liu M, Ying M, Gao W, Jiang H, Wang |
|
Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma.
PloS one 2015 10 (10): e0140819. Havranek Ondrej, Kleiblova Petra, Hojny Jan, Lhota Filip, Soucek Pavel, Trneny Marek, Kleibl Zden |
|
Low prevalence of CHEK2 gene mutations in multiethnic cohorts of breast cancer patients in Malaysia.
PloS one 2015 10 (1): e0117104. Mohamad Suriati, Isa Nurismah Md, Muhammad Rohaizak, Emran Nor Aina, Kitan Nor Mayah, Kang Peter, Kang In Nee, Taib Nur Aishah Mohd, Teo Soo Hwang, Akmal Sharifah No |
|
Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.
PloS one 2015 10 (6): e0130393. Domagala Pawel, Jakubowska Anna, Jaworska-Bieniek Katarzyna, Kaczmarek Katarzyna, Durda Katarzyna, Kurlapska Agnieszka, Cybulski Cezary, Lubinski J |
|
The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population.
SpringerPlus 2015 4 38. Marouf Chaymaa, Hajji Omar, Diakité Brehima, Tazzite Amal, Jouhadi Hassan, Benider Abdellatif, Nadifi Sella |
|
Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.
Cell cycle (Georgetown, Tex.) 2014 13 (14): 2262-80. Ow Ghim Siong, Ivshina Anna V, Fuentes Gloria, Kuznetsov Vladimir |
|
Haplotype analysis of eight genes of the monoubiquitinated FANCD2-DNA damage-repair pathway in breast cancer patients.
Cancer epidemiology 2013 Jun 37 (3): 311-7. Tang Li-Li, Chen Fei-Yu, Wang Hao, Hu Xue-Li, Dai Xu, Mao Jie, Shen Zheng-Tang, Wu Yu-Hui, Wang Shou-Man, Hai Jian, Yan Guo-Jiao, Li Hui, Huang Ju |
|
The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis.
DNA and cell biology 2013 Jun 32 (6): 329-35. Han Fei-fei, Guo Chang-long, Liu Li-ho |
|
The risk of gastric cancer in carriers of CHEK2 mutations.
Familial cancer 2013 Jan . Teodorczyk U, Cybulski C, Woko?orczyk D, Jakubowska A, Starzy?ska T, Lawniczak M, Domaga?a P, Ferenc K, Marlicz K, Banaszkiewicz Z, Wi?niowski R, Narod SA, Lubi?ski J |
|
Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.
PloS one 2013 8 (3): e57581. Carraro Dirce Maria, Koike Folgueira Maria Aparecida Azevedo, Garcia Lisboa Bianca Cristina, Ribeiro Olivieri Eloisa Helena, Vitorino Krepischi Ana Cristina, de Carvalho Alex Fiorini, de Carvalho Mota Louise Danielle, Puga Renato David, do Socorro Maciel Maria, Michelli Rodrigo Augusto Depieri, de Lyra Eduardo Carneiro, Grosso Stana Helena Giorgi, Soares Fernando Augusto, Achatz Maria Isabel Alves de Souza Waddington, Brentani Helena, Moreira-Filho Carlos Alberto, Brentani Maria Mit |
|
Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.
BMC cancer 2013 13 312. Rashid Muhammad U, Muhammad Noor, Faisal Saima, Amin Asim, Hamann U |
|
CHEK2 1100DELC germline mutation: a frequency study in hereditary breast and colon cancer Brazilian families.
Arquivos de gastroenterologia 2012 Dec 49 (4): 273-8. Abud Jamile, Prolla João Carlos, |
|
An inherited NBN mutation is associated with poor prognosis prostate cancer.
British journal of cancer 2012 Nov . Cybulski C, Woko?orczyk D, Klu?niak W, Jakubowska A, Górski B, Gronwald J, Huzarski T, Kashyap A, Byrski T, D?bniak T, Go??b A, Gliniewicz B, Sikorski A, Swita?a J, Borkowski T, Borkowski A, Antczak A, Wojnar L, Przyby?a J, Sosnowski M, Ma?kiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Ró?a?ski W, Ki? J, Bar K, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, S?upski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domaga?a P, Narod SA, Lubi?ski J |
|
CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population.
Cancer epidemiology 2012 Oct 36 (5): 453-7. Bayram Süleyman, Topakta? Mehmet, Akk?z Hikmet, Bekar Aynur, Akgöllü Ers |
|
CHEK2 gene alterations independently increase the risk of death from breast cancer in Bulgarian patients.
Neoplasma 2012 59 (6): 622-30. Angelova S G, Krasteva M E, Gospodinova Z I, Georgieva E |
|
Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population.
Molecular biology reports 2011 Dec . Gu H, Qiu W, Wan Y, Ding G, Tang W, Liu C, Shi Y, Chen Y, Chen S |
|
Absence of the CHEK2*1100delC mutation in non-BRCA1/2 families with multiple cancer types in a high-risk clinic population of Caucasian ancestry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 (15_suppl): 11040. Gorin M A, Iniesta M D, Douglas J A, Milliron K J, Merajver S |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: